Gara Jalqabaatti › Leukemia Lymphoblasticii Hamaa › Texas › Houston
Qorannoo klinikaalii Leukemia Lymphoblasticii Hamaa Houston, TX keessatti
Qorannoo 28 Leukemia Lymphoblasticii Hamaa f Houston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Namoota walitti qabaa jiraSadarkaa 1
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- UT MD Anderson Cancer Center, Houston
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Namoota walitti qabaa jiraQorannoo ilaalaa
- Texas Children's Hospital, Houston
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- University of Texas MD Anderson Cancer Center, Houston
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Namoota walitti qabaa jiraSadarkaa 2
- MD Anderson Cancer Center, Houston
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
Namoota walitti qabaa jiraQorannoo ilaalaa
- Texas Children's Hospital, Houston
Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Namoota walitti qabaa jiraSadarkaa 1/2
- MD Anderson Cancer Center, Houston
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Namoota walitti qabaa jiraSadarkaa 1
- Texas Children's Hospital, Houston
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Namoota walitti qabaa jiraSadarkaa 1/2
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- UT MD Anderson Cancer Center, Houston
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Namoota walitti qabaa jiraSadarkaa 2
- Baylor Texas Children's Hospital, Houston
A Study of CTD402 in T-ALL/LBL Patients
Namoota walitti qabaa jiraSadarkaa 1/2
- MD Anderson Cancer Center, Houston
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Namoota walitti qabaa jiraQorannoo ilaalaa
- Baylor College of Medicine Houston, Houston
Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)
Namoota walitti qabaa jiraSadarkaa 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
Namoota walitti qabaa jiraSadarkaa 2
- M D Anderson Cancer Center, Houston
Personalized NK Cell Therapy in CBT
Namoota walitti qabaa jiraSadarkaa 2
- M D Anderson Cancer Center, Houston
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, Houston
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, Houston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital - Baylor Medical Center, Houston
A Study of Revumenib and Mezigdomide in People With Leukemia
Namoota walitti qabaa jiraSadarkaa 1/2
- MD Anderson Cancer Center (Data Collection Only), Houston
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Namoota walitti qabaa jiraSadarkaa 1/2
- MD Anderson, Houston
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
Namoota walitti qabaa jiraSadarkaa 2
- M D Anderson Cancer Center, Houston
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Namoota walitti qabaa jiraQorannoo ilaalaa
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Namoota walitti qabaa jiraSadarkaa 1
- MD Anderson Cancer Center, Houston
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Namoota walitti qabaa jiraSadarkaa 3
- Ascentage Investigative Site #1501, Houston
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Namoota walitti qabaa jiraSadarkaa 1/2
- MDACC, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 2
- MD Anderson, Houston
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
Namoota walitti qabaa jiraSadarkaa 1
- University of Texas MD Anderson Cancer Center, Houston
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Texas Children's Hospital/Baylor College of Medicine, Houston
Qorannoo Leukemia Lymphoblasticii Hamaa magaalota biroo keessatti
- New York City, NYQorannoo 24
- Baldwin Park, CAQorannoo 21
- Seattle, WAQorannoo 21
- Atlanta, GAQorannoo 19
- Chicago, ILQorannoo 19
- Memphis, TNQorannoo 16
- Philadelphia, PAQorannoo 16
- Washington, DCQorannoo 16
- Boston, MAQorannoo 15
- Los Angeles, CAQorannoo 14
- Durham, NCQorannoo 13
- Mountain View, CAQorannoo 13
Qorannoo biroo Houston keessatti
- Kansara Qara'a Non-Small CellQorannoo 145
- Saree OljooQorannoo 126
- Saree (Gosoota Hunda)Qorannoo 121
- Kansara MetastatikiiQorannoo 104
- Kansarii ColorectalQorannoo 102
- Kansarii OvariiQorannoo 89
- Leukemia Myeloidii HamaaQorannoo 85
- Dhibee QaraQorannoo 78
- Kansarii ProstateQorannoo 76
- Kansa EndometiriyaaliiQorannoo 68
- Kansarii PancreasQorannoo 61
- MelanomaQorannoo 59
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.